Middle East Pharmaceutical Industries Company (TADAWUL:4016)

TADAWUL:4016 Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	15.52	34.37	22.65	15.11	23.79	19.04
Cash & Short-Term Investments	44.07	34.37	22.65	15.11	23.79	19.04
Cash Growth	81.61%	51.78%	49.90%	-36.50%	24.98%	19.54%
Accounts Receivable	295.91	256.84	217.48	163.37	151.57	164.37
Other Receivables	8.05	4.21	8.01	2.16	3.15	2.68
Receivables	303.96	261.05	225.49	165.52	154.73	167.05
Inventory	115.69	103.53	93.6	87.17	100.21	74.45
Prepaid Expenses	4.75	4.45	4.12	2.74	3.41	3.26
Other Current Assets	11.02	9.85	9.57	14.95	9.36	5.57
Total Current Assets	479.49	413.25	355.42	285.49	291.5	269.37
Property, Plant & Equipment	136.35	123.92	120.76	119.08	105.86	103.45
Long-Term Investments	-	-	-	1.32	3.61	9.82
Other Intangible Assets	21.76	62.36	50.59	46.85	41.49	34.29
Total Assets	689.41	599.53	526.78	452.74	442.45	416.93

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	57.37	44.02	27.35	28.04	37.95	32.73
Accrued Expenses	20.04	25.38	26.44	16.58	10.91	7.31
Short-Term Debt	71.76	37.39	60.09	52.5	69.13	66.44
Current Portion of Long-Term Debt	6.37	4.57	3.17	6.34	6.34	4.75
Current Portion of Leases	0.21	0.31	-	-	-	-
Current Income Taxes Payable	4.22	7.69	7.09	5.43	5.59	4.79
Other Current Liabilities	17.75	12.66	9.89	12.2	1.68	1.37
Total Current Liabilities	177.72	132.02	134.04	121.08	131.59	117.39
Long-Term Debt	32.96	21.41	-	3.17	9.51	15.84
Long-Term Leases	0.19	0.16	-	-	-	-
Pension & Post-Retirement Benefits	32.99	29.69	24.54	22.1	21.08	16.61
Total Liabilities	243.86	183.29	158.57	146.35	162.18	149.85

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	350	200	200	200	200	60
Retained Earnings	109.27	229.97	179.96	133.07	104.63	221.53
Comprehensive Income & Other	-13.72	-13.73	-11.75	-26.67	-24.36	-14.45
Shareholders' Equity	445.55	416.24	368.21	306.4	280.27	267.08
Total Liabilities & Equity	689.41	599.53	526.78	452.74	442.45	416.93

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	111.49	63.84	63.26	62	84.97	87.04
Net Cash (Debt)	-67.41	-29.47	-40.61	-46.9	-61.18	-68
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.93	-0.84	-1.16	-1.34	-1.75	-1.94
Filing Date Shares Outstanding	35	35	35	35	35	35
Total Common Shares Outstanding	35	35	35	35	35	35
Working Capital	301.77	281.23	221.39	164.41	159.91	151.98
Book Value Per Share	12.73	11.89	10.52	8.75	8.01	7.63
Tangible Book Value	423.79	353.88	317.62	259.55	238.79	232.79
Tangible Book Value Per Share	12.11	10.11	9.07	7.42	6.82	6.65
Land	21.08	15.83	15.83	15.83	10.19	10.19
Buildings	97.13	96.6	96.36	89.12	86.53	54.19
Machinery	97.39	93.69	84.29	61.65	56.99	52.95
Construction In Progress	19.05	9.74	4.9	24.99	17.33	46

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error